Cysteine-containing peptides having antioxidant properties

Bielicki, John K

Advanced Search OptionsAdvanced Search queries use a traditional Term Search. For more info, see our FAQ.

All Fields:

Patent Title:

Abstract:

Assignee:

Inventor(s):

Patent Number:

Patent Classification (CPC):

All Classifications
A - human necessities
A01 - agriculture
A21 - baking
A22 - butchering
A23 - foods or foodstuffs
A24 - tobacco
A41 - wearing apparel
A42 - headwear
A43 - footwear
A44 - haberdashery
A45 - hand or travelling articles
A46 - brushware
A47 - furniture
A61 - medical or veterinary science
A62 - life-saving
A63 - sports
A99 - subject matter not otherwise provided for in this section
B - performing operations
B01 - physical or chemical processes or apparatus in general
B02 - crushing, pulverising, or disintegrating
B03 - separation of solid materials using liquids or using pneumatic tables or jigs
B04 - centrifugal apparatus or machines for carrying-out physical or chemical processes
B05 - spraying or atomising in general
B06 - generating or transmitting mechanical vibrations in general
B07 - separating solids from solids
B08 - cleaning
B09 - disposal of solid waste
B21 - mechanical metal-working without essentially removing material
B22 - casting
B23 - machine tools
B24 - grinding
B25 - hand tools
B26 - hand cutting tools
B27 - working or preserving wood or similar material
B28 - working cement, clay, or stone
B29 - working of plastics
B30 - presses
B31 - making articles of paper, cardboard or material worked in a manner analogous to paper
B32 - layered products
B33 - additive manufacturing technology
B41 - printing
B42 - bookbinding
B43 - writing or drawing implements
B44 - decorative arts
B60 - vehicles in general
B61 - railways
B62 - land vehicles for travelling otherwise than on rails
B63 - ships or other waterborne vessels
B64 - aircraft
B65 - conveying
B66 - hoisting
B67 - opening, closing {or cleaning} bottles, jars or similar containers
B68 - saddlery
B81 - microstructural technology
B82 - nanotechnology
B99 - subject matter not otherwise provided for in this section
C - chemistry
C01 - inorganic chemistry
C02 - treatment of water, waste water, sewage, or sludge
C03 - glass
C04 - cements
C05 - fertilisers
C06 - explosives
C07 - organic chemistry
C08 - organic macromolecular compounds
C09 - dyes
C10 - petroleum, gas or coke industries
C11 - animal or vegetable oils, fats, fatty substances or waxes
C12 - biochemistry
C13 - sugar industry
C14 - skins
C21 - metallurgy of iron
C22 - metallurgy
C23 - coating metallic material
C25 - electrolytic or electrophoretic processes
C30 - crystal growth
C40 - combinatorial technology
C99 - subject matter not otherwise provided for in this section
D - textiles
D01 - natural or man-made threads or fibres
D02 - yarns
D03 - weaving
D04 - braiding
D05 - sewing
D06 - treatment of textiles or the like
D07 - ropes
D10 - indexing scheme associated with sublasses of section d, relating to textiles
D21 - paper-making
D99 - subject matter not otherwise provided for in this section
E - fixed constructions
E01 - construction of roads, railways, or bridges
E02 - hydraulic engineering
E03 - water supply
E04 - building
E05 - locks
E06 - doors, windows, shutters, or roller blinds in general
E21 - earth drilling
E99 - subject matter not otherwise provided for in this section
F - mechanical engineering
F01 - machines or engines in general
F02 - combustion engines
F03 - machines or engines for liquids
F04 - positive - displacement machines for liquids
F05 - indexing schemes relating to engines or pumps in various subclasses of classes f01-f04
F15 - fluid-pressure actuators
F16 - engineering elements and units
F17 - storing or distributing gases or liquids
F21 - lighting
F22 - steam generation
F23 - combustion apparatus
F24 - heating
F25 - refrigeration or cooling
F26 - drying
F27 - furnaces
F28 - heat exchange in general
F41 - weapons
F42 - ammunition
F99 - subject matter not otherwise provided for in this section
G - physics
G01 - measuring
G02 - optics
G03 - photography
G04 - horology
G05 - controlling
G06 - computing
G07 - checking-devices
G08 - signalling
G09 - education
G10 - musical instruments
G11 - information storage
G12 - instrument details
G16 - information and communication technology [ict] specially adapted for specific application fields
G21 - nuclear physics
G99 - subject matter not otherwise provided for in this section
H - electricity
H01 - basic electric elements
H02 - generation
H03 - basic electronic circuitry
H04 - electric communication technique
H05 - electric techniques not otherwise provided for
H99 - subject matter not otherwise provided for in this section
Y - new / cross sectional technologies
Y02 - technologies or applications for mitigation or adaptation against climate change
Y04 - information or communication technologies having an impact on other technology areas
Y10 - technical subjects covered by former uspc

More Options ...

Title: Cysteine-containing peptides having antioxidant properties

Abstract

Cysteine containing amphipathic alpha helices of the exchangeable apolipoproteins, as exemplified by apolipoprotein (apo) A-I.sub.Milano (R173C) and apoA-I.sub.Paris, (R151C) were found to exhibit potent antioxidant activity on phospholipid surfaces. The addition of a free thiol, at the hydrophobic/hydrophilic interface of an amphipathic alpha helix of synthetic peptides that mimic HDL-related proteins, imparts a unique antioxidant activity to these peptides which inhibits lipid peroxidation and protects phospholipids from water-soluble free radical initiators. These peptides can be used as therapeutic agents to combat cardiovascular disease, ischemia, bone disease and other inflammatory related diseases.

Inventors:

Bielicki, John K ^[1]

Castro Valley, CA

Issue Date:: Tue Oct 13 00:00:00 EDT 2009

Research Org.:: Univ. of California (United States)

Sponsoring Org.:: USDOE

OSTI Identifier:: 1001794

Patent Number(s):: 7601802

Application Number:: 11/177,225

Assignee:: The Regents of the University of California (Oakland, CA)

Patent Classifications (CPCs):: A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES

C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES

Show more

A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
A61K38/00 - Medicinal preparations containing peptides

C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
C07K14/775 - Apolipopeptides

Show less

DOE Contract Number:: AC03-76SF00098

Resource Type:: Patent

Country of Publication:: United States

Language:: English

Subject:: 60 APPLIED LIFE SCIENCES

Citation Formats


                    Bielicki, John K. Cysteine-containing peptides having antioxidant properties.  United States: N. p., 2009. 
        Web.

Copy to clipboard


                    Bielicki, John K. Cysteine-containing peptides having antioxidant properties.  United States.

Copy to clipboard


                    Bielicki, John K. Tue .  
        "Cysteine-containing peptides having antioxidant properties".  United States.  https://www.osti.gov/servlets/purl/1001794.

Copy to clipboard


                    
@article{osti_1001794,

  title        = {Cysteine-containing peptides having antioxidant properties},

  author       = {Bielicki, John K},

  abstractNote = {Cysteine containing amphipathic alpha helices of the exchangeable apolipoproteins, as exemplified by apolipoprotein (apo) A-I.sub.Milano (R173C) and apoA-I.sub.Paris, (R151C) were found to exhibit potent antioxidant activity on phospholipid surfaces. The addition of a free thiol, at the hydrophobic/hydrophilic interface of an amphipathic alpha helix of synthetic peptides that mimic HDL-related proteins, imparts a unique antioxidant activity to these peptides which inhibits lipid peroxidation and protects phospholipids from water-soluble free radical initiators. These peptides can be used as therapeutic agents to combat cardiovascular disease, ischemia, bone disease and other inflammatory related diseases.},

  doi          = {},

  journal      = {},
number       = ,

  volume       = ,

  place        = {United States},

  year         = {Tue Oct 13 00:00:00 EDT 2009},

  month        = {Tue Oct 13 00:00:00 EDT 2009}

}

Copy to clipboard

Patent:

Save / Share:

Export Metadata

Save to My Library

Works referenced in this record:

Studies of Synthetic Peptides of Human Apolipoprotein A-I Containing Tandem Amphipathic α-Helixes ^†
journal, July 1998

Mishra, Vinod K.; Palgunachari, Mayakonda N.; Datta, Geeta
Biochemistry, Vol. 37, Issue 28
https://doi.org/10.1021/bi980042o

High-density lipoprotein cholesterol and coronary artery disease: Survey of the evidence
journal, September 1990

Rifkind, Basil M.
The American Journal of Cardiology, Vol. 66, Issue 6
https://doi.org/10.1016/0002-9149(90)90561-E

Thiol-bearing synthetic peptides retain the antioxidant activity of apolipoproteinA-IMilano
journal, September 2002

Jia, Zhen; Natarajan, Pradeep; Forte, Trudy M.
Biochemical and Biophysical Research Communications, Vol. 297, Issue 2
https://doi.org/10.1016/S0006-291X(02)02143-5

The replacement of arginine by cysteine at residue 151 in Apolipoprotein A-I produces a phenotype similar to that of Apolipoprotein A-I Milano
journal, January 1997

Bruckert, Eric; von Eckardstein, Arnold; Funke, Harald
Atherosclerosis, Vol. 128, Issue 1
https://doi.org/10.1016/S0021-9150(96)05982-5

The Hydrophobic Face Orientation of Apolipoprotein A-I Amphipathic Helix Domain 143–164 Regulates Lecithin:Cholesterol Acyltransferase Activation
journal, May 1998

Sorci-Thomas, Mary G.; Curtiss, Linda; Parks, John S.
Journal of Biological Chemistry, Vol. 273, Issue 19
https://doi.org/10.1074/jbc.273.19.11776

High-density lipoprotein, low-density lipoprotein and coronary artery disease
journal, September 1990

Wilson, Peter W. F.
The American Journal of Cardiology, Vol. 66, Issue 6
https://doi.org/10.1016/0002-9149(90)90562-F

Aromatic Residue Position on the Nonpolar Face of Class A Amphipathic Helical Peptides Determines Biological Activity
journal, April 2004

Datta, Geeta; Epand, Raquel F.; Epand, Richard M.
Journal of Biological Chemistry, Vol. 279, Issue 25
https://doi.org/10.1074/jbc.M314276200

Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.
journal, October 1994

Mendez, A. J.; Anantharamaiah, G. M.; Segrest, J. P.
Journal of Clinical Investigation, Vol. 94, Issue 4
https://doi.org/10.1172/JCI117515

Only the Two End Helixes of Eight Tandem Amphipathic Helical Domains of Human Apo A-I Have Significant Lipid Affinity: Implications for HDL Assembly
journal, February 1996

Palgunachari, Mayakonda N.; Mishra, Vinod K.; Lund-Katz, Sissel
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 16, Issue 2
https://doi.org/10.1161/01.ATV.16.2.328

Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
journal, April 2004

Navab, Mohamad; Ananthramaiah, G. M.; Reddy, Srinivasa T.
Journal of Lipid Research, Vol. 45, Issue 6
https://doi.org/10.1194/jlr.R400001-JLR200

Effects of Recombinant Apolipoprotein A-I _Milano on Aortic Atherosclerosis in Apolipoprotein E–Deficient Mice
journal, March 1998

Shah, Prediman K.; Nilsson, Jan; Kaul, Sanjay
Circulation, Vol. 97, Issue 8
https://doi.org/10.1161/01.CIR.97.8.780

High-Dose Recombinant Apolipoprotein A-I _Milano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E–Deficient Mice: Potential Implications for Acute Plaque Stabilization
journal, June 2001

Shah, Prediman K.; Yano, Juliana; Reyes, Odette
Circulation, Vol. 103, Issue 25
https://doi.org/10.1161/hc2501.092494

Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits.
journal, October 1994

Ameli, S.; Hultgardh-Nilsson, A.; Cercek, B.
Circulation, Vol. 90, Issue 4
https://doi.org/10.1161/01.CIR.90.4.1935

Alteration in Apolipoprotein A-I 22-Mer Repeat Order Results in a Decrease in Lecithin:Cholesterol Acyltransferase Reactivity
journal, March 1997

Sorci-Thomas, Mary G.; Curtiss, Linda; Parks, John S.
Journal of Biological Chemistry, Vol. 272, Issue 11
https://doi.org/10.1074/jbc.272.11.7278

Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris
journal, February 2000

Perez-Mendez, Oscar; Bruckert, Eric; Franceschini, Guido
Atherosclerosis, Vol. 148, Issue 2
https://doi.org/10.1016/S0021-9150(99)00279-8

ATP-Binding Cassette Transporter A1 (ABCA1) in Macrophages: A Dual Function in Inflammation and Lipid Metabolism?
journal, January 1999

Schmitz, G.; Kaminski, W. E.; Porsch-Özcürümez, M.
Pathobiology, Vol. 67, Issue 5-6
https://doi.org/10.1159/000028100

Apolipoprotein A-I _Milano and Apolipoprotein A-I _Paris Exhibit an Antioxidant Activity Distinct from That of Wild-Type Apolipoprotein A-I ^†
journal, February 2002

Bielicki, John K.; Oda, Michael N.
Biochemistry, Vol. 41, Issue 6
https://doi.org/10.1021/bi011716p

Cysteine Substitutions in Apolipoprotein A-I Primary Structure Modulate Paraoxonase Activity ^†
journal, February 2001

Oda, Michael N.; Bielicki, John K.; Berger, Trish
Biochemistry, Vol. 40, Issue 6
https://doi.org/10.1021/bi001922h

ATP-Binding Cassette Transporter 1 Participates in LDL Oxidation by Artery Wall Cells
journal, November 2002

Reddy, Srinivasa T.; Hama, Susan; Ng, Carey
Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 22, Issue 11
https://doi.org/10.1161/01.ATV.0000035700.82829.2A

Cardiovascular Status of Carriers of the Apolipoprotein A-I _Milano Mutant: The Limone sul Garda Study
journal, April 2001

Sirtori, Cesare R.; Calabresi, Laura; Franceschini, Guido
Circulation, Vol. 103, Issue 15
https://doi.org/10.1161/01.CIR.103.15.1949

A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins.
journal, November 1980

Weisgraber, K. H.; Bersot, T. P.; Mahley, R. W.
Journal of Clinical Investigation, Vol. 66, Issue 5
https://doi.org/10.1172/JCI109957

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.
journal, November 1980

Franceschini, G.; Sirtori, C. R.; Capurso, A.
Journal of Clinical Investigation, Vol. 66, Issue 5
https://doi.org/10.1172/JCI109956

Apolipoprotein-mediated Plasma Membrane Microsolubilization: ROLE OF LIPID AFFINITY AND MEMBRANE PENETRATION IN THE EFFLUX OF CELLULAR CHOLESTEROL AND PHOSPHOLIPID
journal, January 1999

Gillotte, Kristin L.; Zaiou, Mohamed; Lund-Katz, Sissel
Journal of Biological Chemistry, Vol. 274, Issue 4
https://doi.org/10.1074/jbc.274.4.2021

Similar Records in DOE Patents and OSTI.GOV collections:

Cysteine-containing peptides having antioxidant properties

Patent Bielicki, John K [Castro Valley, CA]

Cysteine containing amphipathic alpha helices of the exchangeable apolipoproteins, as exemplified by apolipoprotein (apo) A-I.sub.Milano (R173C) and apoA-I.sub.Paris, (R151C) were found to exhibit potent antioxidant activity on phospholipid surfaces. The addition of a free thiol, at the hydrophobic/hydrophilic interface of an amphipathic alpha helix of synthetic peptides that mimic HDL-related proteins, imparts a unique antioxidant activity to these peptides which inhibits lipid peroxidation and protects phospholipids from water-soluble free radical initiators. These peptides can be used as therapeutic agents to combat cardiovascular disease, ischemia, bone disease and other inflammatory related diseases.
Full Text Available
Cysteine-containing peptides having antioxidant properties

Patent Bielicki, John K [Castro Valley, CA]

The term "homology" or "homologous" means an amino acid similarity measured by the program, BLAST (Altschul et al (1997), "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs", Nucleic Acids Res. 25:33 89 3402), and expressed as --(% identity n/n). In measuring homology between a peptide and a protein of greater size, homology is measured only in the corresponding region; that is, the protein is regarded as only having the same general length as the peptide, allowing for gaps and insertions.
Full Text Available
Cysteine-containing peptide tag for site-specific conjugation of proteins

Patent Backer, Marina V [W. Simsbury, CT]; Backer, Joseph M [W. Simsbury, CT]

The present invention is directed to a biological conjugate, comprising: (a) a targeting moiety comprising a polypeptide having an amino acid sequence comprising the polypeptide sequence of SEQ ID NO:2 and the polypeptide sequence of a selected targeting protein; and (b) a binding moiety bound to the targeting moiety; the biological conjugate having a covalent bond between the thiol group of SEQ ID NO:2 and a functional group in the binding moiety. The present invention is directed to a biological conjugate, comprising: (a) a targeting moiety comprising a polypeptide having an amino acid sequence comprising the polypeptide sequence of SEQmore » « less
Full Text Available
Cysteine-containing peptide tag for site-specific conjugation of proteins

Patent Backer, Marina V [Simsbury, CT]; Backer, Joseph M [Simsbury, CT]

The present invention is directed to a biological conjugate, comprising: (a) a targeting moiety comprising a polypeptide having an amino acid sequence comprising the polypeptide sequence of SEQ ID NO:2 and the polypeptide sequence of a selected targeting protein; and (b) a binding moiety bound to the targeting moiety; the biological conjugate having a covalent bond between the thiol group of SEQ ID NO:2 and a functional group in the binding moiety. The present invention is directed to a biological conjugate, comprising: (a) a targeting moiety comprising a polypeptide having an amino acid sequence comprising the polypeptide sequence of SEQmore » « less
Full Text Available
Methanobactin: a copper binding compound having antibiotic and antioxidant activity isolated from methanotrophic bacteria

Patent DiSpirito, Alan A [Ames, IA]; Zahn, James A [Harbor Beach, MI]; Graham, David W [Lawrence, KS]; ...

A means and method for treating bacterial infection, providing antioxidant activity, and chelating copper using a copper binding compound produced by methanotrophic bacteria is described. The compound, known as methanobactin, is the first of a new class of antibiotics having gram-positive activity. Methanobactin has been sequenced, and its structural formula determined.
Full Text Available

Similar Records

Title: Cysteine-containing peptides having antioxidant properties

Abstract

Citation Formats

Studies of Synthetic Peptides of Human Apolipoprotein A-I Containing Tandem Amphipathic α-Helixes † journal, July 1998

High-density lipoprotein cholesterol and coronary artery disease: Survey of the evidence journal, September 1990

Thiol-bearing synthetic peptides retain the antioxidant activity of apolipoproteinA-IMilano journal, September 2002

The replacement of arginine by cysteine at residue 151 in Apolipoprotein A-I produces a phenotype similar to that of Apolipoprotein A-I Milano journal, January 1997

The Hydrophobic Face Orientation of Apolipoprotein A-I Amphipathic Helix Domain 143–164 Regulates Lecithin:Cholesterol Acyltransferase Activation journal, May 1998

High-density lipoprotein, low-density lipoprotein and coronary artery disease journal, September 1990

Aromatic Residue Position on the Nonpolar Face of Class A Amphipathic Helical Peptides Determines Biological Activity journal, April 2004

Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. journal, October 1994

Only the Two End Helixes of Eight Tandem Amphipathic Helical Domains of Human Apo A-I Have Significant Lipid Affinity: Implications for HDL Assembly journal, February 1996

Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL journal, April 2004

Effects of Recombinant Apolipoprotein A-I Milano on Aortic Atherosclerosis in Apolipoprotein E–Deficient Mice journal, March 1998

High-Dose Recombinant Apolipoprotein A-I Milano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E–Deficient Mice: Potential Implications for Acute Plaque Stabilization journal, June 2001

Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. journal, October 1994

Alteration in Apolipoprotein A-I 22-Mer Repeat Order Results in a Decrease in Lecithin:Cholesterol Acyltransferase Reactivity journal, March 1997

Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris journal, February 2000

ATP-Binding Cassette Transporter A1 (ABCA1) in Macrophages: A Dual Function in Inflammation and Lipid Metabolism? journal, January 1999

Apolipoprotein A-I Milano and Apolipoprotein A-I Paris Exhibit an Antioxidant Activity Distinct from That of Wild-Type Apolipoprotein A-I † journal, February 2002

Cysteine Substitutions in Apolipoprotein A-I Primary Structure Modulate Paraoxonase Activity † journal, February 2001

ATP-Binding Cassette Transporter 1 Participates in LDL Oxidation by Artery Wall Cells journal, November 2002

Cardiovascular Status of Carriers of the Apolipoprotein A-I Milano Mutant: The Limone sul Garda Study journal, April 2001

A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins. journal, November 1980

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. journal, November 1980

Apolipoprotein-mediated Plasma Membrane Microsolubilization: ROLE OF LIPID AFFINITY AND MEMBRANE PENETRATION IN THE EFFLUX OF CELLULAR CHOLESTEROL AND PHOSPHOLIPID journal, January 1999

Studies of Synthetic Peptides of Human Apolipoprotein A-I Containing Tandem Amphipathic α-Helixes ^†
journal, July 1998

High-density lipoprotein cholesterol and coronary artery disease: Survey of the evidence
journal, September 1990

Thiol-bearing synthetic peptides retain the antioxidant activity of apolipoproteinA-IMilano
journal, September 2002

The replacement of arginine by cysteine at residue 151 in Apolipoprotein A-I produces a phenotype similar to that of Apolipoprotein A-I Milano
journal, January 1997

The Hydrophobic Face Orientation of Apolipoprotein A-I Amphipathic Helix Domain 143–164 Regulates Lecithin:Cholesterol Acyltransferase Activation
journal, May 1998

High-density lipoprotein, low-density lipoprotein and coronary artery disease
journal, September 1990

Aromatic Residue Position on the Nonpolar Face of Class A Amphipathic Helical Peptides Determines Biological Activity
journal, April 2004

Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.
journal, October 1994

Only the Two End Helixes of Eight Tandem Amphipathic Helical Domains of Human Apo A-I Have Significant Lipid Affinity: Implications for HDL Assembly
journal, February 1996

Thematic review series: The Pathogenesis of Atherosclerosis The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL
journal, April 2004

Effects of Recombinant Apolipoprotein A-I _Milano on Aortic Atherosclerosis in Apolipoprotein E–Deficient Mice
journal, March 1998

High-Dose Recombinant Apolipoprotein A-I _Milano Mobilizes Tissue Cholesterol and Rapidly Reduces Plaque Lipid and Macrophage Content in Apolipoprotein E–Deficient Mice: Potential Implications for Acute Plaque Stabilization
journal, June 2001

Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits.
journal, October 1994

Alteration in Apolipoprotein A-I 22-Mer Repeat Order Results in a Decrease in Lecithin:Cholesterol Acyltransferase Reactivity
journal, March 1997

Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris
journal, February 2000

ATP-Binding Cassette Transporter A1 (ABCA1) in Macrophages: A Dual Function in Inflammation and Lipid Metabolism?
journal, January 1999

Apolipoprotein A-I _Milano and Apolipoprotein A-I _Paris Exhibit an Antioxidant Activity Distinct from That of Wild-Type Apolipoprotein A-I ^†
journal, February 2002

Cysteine Substitutions in Apolipoprotein A-I Primary Structure Modulate Paraoxonase Activity ^†
journal, February 2001

ATP-Binding Cassette Transporter 1 Participates in LDL Oxidation by Artery Wall Cells
journal, November 2002

Cardiovascular Status of Carriers of the Apolipoprotein A-I _Milano Mutant: The Limone sul Garda Study
journal, April 2001

A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins.
journal, November 1980

A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.
journal, November 1980

Apolipoprotein-mediated Plasma Membrane Microsolubilization: ROLE OF LIPID AFFINITY AND MEMBRANE PENETRATION IN THE EFFLUX OF CELLULAR CHOLESTEROL AND PHOSPHOLIPID
journal, January 1999